ARE three-lens brief
Evidence-based stock research on ARE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · P/E of 104 — priced for high growth; little margin of safety.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- P/E of 104 — priced for high growth; little margin of safety.
ARE closed at $45.08 (+0.85%) as of 2026-11-12. Market cap: $7.85B. P/E (trailing) 103.8. Price is below the 50-day MA and below the 200-day MA. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; p/E of 104 — priced for high growth; little margin of safety.. Last quarter: Revenue $671.18M, net income -$638.45M, free cash flow $1.29B.
Why three lenses on ARE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARE across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARE brief"></iframe>